March 2006: Agreement Cements Unique Liposomal Formulation
Bridge to Life Preservation Solutions Ltd., Milwaukee, Wisconsin, announced an agreement with Vitatech of Louisville, Kentucky, to license Vitatech’s liposomal formulation containing adenosine triphosphate (ATP), which provides energy to living cells.

Bridge to Life has licensed VitaTech’s patent-pending technology to directly infuse cells with energy. Specially engineered vesicles containing ATP are made to fuse with the cell membrane, quickly and efficiently transferring the energy. This allows cells to maintain their function, even in the absence of oxygen. The result is superior preservation, growth, and healing.

Bridge to Life CEO, Stevan Schweighardt, and Vitatech CEO, Patrick Migliore jointly announced the agreement.

Vist our Research section for further details.

April 2006: Agreement with the Wisconsin Alumni Research Foundation
Bridge to Life Preservation Solutions Ltd., Milwaukee, Wisconsin, today announced that 5% of its shares were purchased by the Wisconsin Alumni Research Foundation (WARF)—the first time that WARF has taken an equity position in a startup company.

Bridge to Life Preservation Solutions is a company that manufactures solutions to preserve intra-abdominal organs during transplantation. WARF, one of the most successful university technology transfer organizations, manages intellectual property and oversees research and development as an arm of the University of Wisconsin.

In addition to an ownership stake, WARF will provide to Bride to Life specified rights to future patents and products that enhance the science of organ transplantation. One example in the making is purchase of an additive that may help prevent organ rejection.

March 2006: Michael F. Holick, M.D., Ph.D., President of Bridge to Life, Director of the Medical Advisory Board, is Honored by the National Center for Research Resources

Boston, MA –Michael F. Holick, Ph.D., M.D. director of the General Clinical Research Center and Professor of Medicine, Physiology and Biophysics at Boston University Medical Center (BUSM) is this year’s recipient of the 18th awarding of the General Clinical Research Center Excellence in Clinical Research Award by the National Center for Research Resources at the NIH. Holick received this distinction at the GCRC annual meeting that was held in Washington, DC, on March 18th. He was honored for his ongoing contributions in clinical research that have touched the lives and improved the health of millions of people worldwide.

Holick, who is also the director of the Bone Healthcare Clinic and director of the vitamin D, Skin and Bone Research Laboratory at Boston University Medical Center, is internationally recognized for his expertise in vitamin D, skin and bone research. His pioneering research in vitamin D nutrition has provided important insights regarding the connection between sensible sun exposure and vitamin D and its importance for improving bone health and decreasing risk of many chronic diseases including cancers of the colon, prostate and breast and hypertension and cardiovascular heart disease. He has increased the public’s awareness that upwards of 50% of both children and adults in the United States are vitamin D deficient. His group conducted the seminal study that demonstrated that vitamin D could be added to orange juice that has made a contribution to vitamin D health for the US population. Dr. Holick revolutionized the treatment for psoriasis by introducing the use of activated vitamin D compounds which have proven to be very successful and safe for both children and adults.

After completing his Ph.D. and M.D.degrees at the University of Wisconsin in 1971 and 1976 respectively, Holick joined the staff at the Massachusetts General Hospital where he did an internship and residency in medicine while simultaneously initiating a basic and clinical research program on the photobiology of vitamin D. This research has led to our understanding of the role of season, latitude, aging and skin pigmentation on the capacity of the human body to produce vitamin D.

Over the past two decades at Boston University Medical Center, Dr. Holick has made major contributions in the fields of skin disease, hair loss, osteoporosis and metabolic bone disease.

Holick has received numerous honors and awards for his innovative clinical research activities including the McCollum Award the Robert H. Herman Memorial Award in Clinical Nutrition from the American Society for Clinical Nutrition for his innovative research in the field of photobiology. He also received the Psoriasis Research Achievement Award from the America Skin Association for his novel approach for treating psoriasis.

February 2006: Howard Bremer, Legal Counsel, Awarded the Jefferson Medal

The New Jersey Intellectual Property Law Association announced that it was awarding its prestigious Jefferson Medal to Howard Bremer, former patent counsel to the Wisconsin Alumni Research Foundation, and current legal counsel to Bridge to Life Preservations Solutions, Ltd. The Jefferson Medal is awarded annually to one attorney with a lifetime achievement of work in "the protection of intellectual property including patents, trademarks and copyrights [which] is essential to the progress and promotion of the useful arts." Past recipients have included luminaries such as Charles Kettering, Edward Vandenburgh III, Robert W. Kastenmeier, Orrin G. Hatch, and Marybeth Peters. The award ceremony will take place on June 2 at the Hilton Hotel in Short Hills, New Jersey.